Bipartisan AGs Reach $49 Million Settlement over Alleged Price-Fixing in Generic Drugs Market
A bipartisan coalition of 50 states, D.C., and two territories reached settlements with Heritage Pharmaceuticals, Inc. and Apotex Corp. to resolve allegations of price fixing generic drugs in violation of the Sherman Act. As part of complaints filed in 2017 and 2019, the AGs allege that the companies, along with other drug manufacturers and their executives,…